RRML - Chronic myelomonocytic leukemia 'myelodysplastic type' in transformation to acute myeloid leukemia - diagnostic and therapeutic options: case report and literature review
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2016): 55%

Română English


SCImago Journal & Country Rank


Advanced search


Top 10 downloaded articles
- December 2019 -
 
Romanian Review of Laboratory ... 13
Undetectable hemoglobin in a p... 6
Hemolysis has no influence on ... 6
The angiotensinogen gene polym... 4
Acute effects of recreational ... 3
The usefulness of neutrophil/l... 3
The influence of hemodialysis ... 3
The role of neutrophil to lymp... 3
The role of inflammation and C... 2
To translate or not to transla... 2

Log in

Concept, Design & Programming
Dr. Adrian Man

   
 
Nr. 24(3)/2016 DOI:10.1515/rrlm-2016-0033
XML
TXT

Review

Chronic myelomonocytic leukemia 'myelodysplastic type' in transformation to acute myeloid leukemia - diagnostic and therapeutic options: case report and literature review

Mihaela Cîrstea, Adriana Coliță, Bogdan Ionescu, Didona Vasilache, Camelia Dobrea, Cerasela Jardan, Mihaela Dragomir, Anca Gheorghe, Delia Codruța Popa, Zsofia Varady, Anca Roxana Lupu, Daniel Coriu

Correspondence should be addressed to: Mihaela Cîrstea

Abstract:

Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic stem cell disorder that is characterized by the presence of an absolute monocytosis (1 x 10^ 9/l) in the peripheral blood, the overlap of myelodisplastic aspects and myeloproliferative aspects in the bone marrow and tendency to transform into acute myeloid leukemia. CMML is considered to be the most aggressive chronic myeloid leukemia. We present the case of a 48 years old woman who was hospitalized in March 2013 in the Center of Hematology and Bone Marrow Transplantation for anemia related symptoms. Initial investigations showed anemia, relative monocytosis (10% monocytes of the WBC differential) with an increasing absolute number of monocytes (> 1,000/µl) in the following months. Initial exploration of the bone marrow (aspirate and bone marrow biopsy and immunohistochemistry IHC tests) revealed elements of trilinear dysplasia and an increased percentage of myeloblasts (11-14%). In the next four months myeloblasts percentage remained below 20% (8-14%) and it has been observed a gradually increasing of monocytoid elements (> 20%). Immunophenotyping in the bone marrow aspirate identified a monocytic proliferation with high percentage (8%) of immature cells. The karyotype reported the presence of clones with t (1: 3). Initially diagnosed as RAEB-2 (WHO) the case was recomitted in CMML-type 2 with a progression to acute myeloid leukemia (AML). Allogeneic hematopoietic stem cell transplantation (allo-HSCT) has been performed after getting the best possible therapeutic response with AML chemotherapy type (complete remission). Allo-HSCT was performed using myeloablative conditioning, 12 months after diagnosis. The patient is now in complete remission, 24 months after allo-HSCT.

Keywords: chronic myelomonocytic leukemia, acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation

Received: 28.6.2016
Accepted: 12.9.2016
Published: 12.9.2016

 
  PDF Download full text PDF
(893 KB)
     
 
How to cite
Cîrstea M, Coliță A, Ionescu B, Vasilache D, Dobrea C, Jardan C, et al. Chronic myelomonocytic leukemia 'myelodysplastic type' in transformation to acute myeloid leukemia - diagnostic and therapeutic options: case report and literature review. Rev Romana Med Lab. 2016;24(3):263-77. DOI:10.1515/rrlm-2016-0033